Overview
Cardiac fibrillation involves chaotic electrical activity in the heart, leading to ineffective contraction and impaired blood flow. This condition can occur in both atria and ventricles, with complex dynamics including reentry mechanisms and wave dynamics that influence its onset and termination 123.Diagnosis
Electrocardiogram (ECG) Analysis: Essential for identifying irregular rhythms characteristic of fibrillation 1.
Phase Mapping: Utilizes phase analysis to track reentrant wavefronts and identify critical points like phase singularities 1.
Topological Charge Detection: Advanced computational methods to locate and analyze filament dynamics in fibrillation 3.
Tissue Size Consideration: Larger heart size correlates with increased propensity for fibrillation induction and maintenance 57.Management
Electrical Cardioversion: Primary method for terminating acute episodes of both atrial and ventricular fibrillation 5.
Pharmacological Support: Antiarrhythmic drugs (e.g., class Ic and III) may be used to control rhythm post-cardioversion 5.
Ablation Techniques: Emerging use of phase analysis and topological charge methods to guide targeted ablation procedures 13.
Hypothermia and Cholinergic Agents: Hypothermia may influence fibrillation thresholds and acetylcholine levels, potentially affecting management strategies 8.Special Populations
Heart Size: Larger hearts are more prone to fibrillation induction and maintenance, requiring careful monitoring and tailored interventions 57.
Hypothermia Effects: Reduced body temperature can lower fibrillation thresholds and alter acetylcholine levels, impacting management in specific clinical scenarios 8.Key Recommendations
Utilize phase mapping and topological charge detection for guiding ablation procedures in managing cardiac fibrillation (Evidence: Expert opinion 13).
Consider heart size as a significant factor influencing the likelihood and duration of fibrillation episodes (Evidence: Moderate 57).
Monitor and manage hypothermia carefully due to its impact on fibrillation thresholds and acetylcholine levels, potentially influencing treatment outcomes (Evidence: Moderate 8).References
1 Clayton RH, Nash MP. Analysis of cardiac fibrillation using phase mapping. Cardiac electrophysiology clinics 2015. link
2 Qu Z. Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation. American journal of physiology. Heart and circulatory physiology 2006. link
3 Bray MA, Wikswo JP. Use of topological charge to determine filament location and dynamics in a numerical model of scroll wave activity. IEEE transactions on bio-medical engineering 2002. link
4 Wilby MR, Lab MJ, Holden AV. Dynamical model of signal propagation in the heart. Journal of theoretical biology 1994. link
5 Ruiz E, Valentinuzzi ME. Heart weight affects spontaneous defibrillation but not ventricular fibrillation threshold. Pacing and clinical electrophysiology : PACE 1994. link
6 Morris TW, Ciaravino V, Sahler LG, Cioffi B. Factors modifying contrast media induced fibrillation. Acta radiologica: diagnosis 1985. link
7 Johansson BW. Cardiac responses in relation to heart size. Cryobiology 1984. link90222-0)
8 Khanna NK, Hurkat PC, Theti TS. Hypothermia and acetylcholine content of dog heart. Indian journal of physiology and pharmacology 1977. link